$101.61
-0.47-0.46%
At close: Aug 31, 5:00 PM EST
$100.57
-1.04-1.02%
After Hours: 4:59 PM EST
BioNTech SE
BNTXNASDAQ
BioNTech Earnings & Forecasts
BioNTech (BNTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
BioNTech Guidance
BioNTech (BNTX) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided revenue in the range of $1.86B - $2.21B for the period.
Compared to prior guidance, BioNTech lowered its revenue forecast from a prior range of $2.33B - $2.68B.
BioNTech has issued 13 guidance updates between January 9, 2024 and August 4, 2026. During this period, the company raised its outlook 1 time and lowered it 6 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.34 | $-2.52 | $-0.47 | $0.75 |
| Actual | $-2.58 | $-2.28 | $-0.38 | $-0.14 |
| Surprise | -10.3% | +9.52% | +19.1% | -118.7% |
| Revenue | ||||
| Estimate | $182.0M | $214.6M | $889.5M | $1.19B |
| Actual | $122.8M | $138.0M | $1.06B | $1.78B |
| Surprise | -32.6% | -35.7% | +18.7% | +49.2% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $0.91 | $-1.34 | $-2.66 |
| Revenue | |||
| Consensus | $1.21B | $688.4M | — |
